Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Reversal agents for oral anticoagulant-associated major or life-threatening bleeding.

Moia M, Squizzato A.

Intern Emerg Med. 2019 Aug 24. doi: 10.1007/s11739-019-02177-2. [Epub ahead of print] Review.

PMID:
31446606
2.

Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension - A Systematic Review and Meta-Analysis.

Zoppellaro G, Badawy MR, Squizzato A, Denas G, Tarantini G, Pengo V.

Circ J. 2019 Jul 25;83(8):1660-1667. doi: 10.1253/circj.CJ-19-0161. Epub 2019 Jun 21.

3.

Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study.

Gallo A, Galliazzo S, Grazioli S, Guasti L, Ageno W, Squizzato A.

J Thromb Thrombolysis. 2019 Aug;48(2):336-344. doi: 10.1007/s11239-019-01893-y.

PMID:
31177486
4.

What Quality and Safety of Care for Patients Admitted to Clinically Inappropriate Wards: a Systematic Review.

La Regina M, Guarneri F, Romano E, Orlandini F, Nardi R, Mazzone A, Fontanella A, Campanini M, Manfellotto D, Bellandi T, Gussoni G, Tartaglia R, Squizzato A.

J Gen Intern Med. 2019 Jul;34(7):1314-1321. doi: 10.1007/s11606-019-05008-4. Epub 2019 Apr 22.

PMID:
31011980
5.

Metabolic tumour volume and response to therapy in diffuse large B-cell lymphoma.

Campiotti L, Suter MB, De Palma D, Proserpio I, Uccella S, Squizzato A.

Hematol Oncol. 2019 Aug;37(3):308-309. doi: 10.1002/hon.2612. Epub 2019 Apr 26. No abstract available.

PMID:
30933368
6.

Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis.

Tramacere I, Boncoraglio GB, Banzi R, Del Giovane C, Kwag KH, Squizzato A, Moja L.

BMC Med. 2019 Mar 26;17(1):67. doi: 10.1186/s12916-019-1298-5.

7.

Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience.

Campiotti L, De Palma D, Guasti L, Proserpio I, Casagrande S, Schiorlin I, Bolzacchini E, Suter M, Ogliari F, Squizzato A.

Q J Nucl Med Mol Imaging. 2019 Feb 14. doi: 10.23736/S1824-4785.19.03130-3. [Epub ahead of print]

PMID:
30781938
8.

sRAGE and early signs of cardiac target organ damage in mild hypertensives.

Maresca AM, Guasti L, Bozzini S, Mongiardi C, Tandurella N, Corso R, Zerba FG, Squizzato A, Campiotti L, Dentali F, Klersy C, Grandi AM, Falcone C.

Cardiovasc Diabetol. 2019 Feb 12;18(1):17. doi: 10.1186/s12933-019-0821-5.

9.

Optimal management of major bleeding on DOACs: not only reversal agents.

Galliazzo S, Squizzato A.

Intern Emerg Med. 2019 Mar;14(2):207-208. doi: 10.1007/s11739-018-02020-0. Epub 2019 Jan 5. No abstract available.

PMID:
30612343
10.

Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.

Giorgi-Pierfranceschi M, Artom N, Di Pasquale G, Squizzato A, Pellegrinet M, Romano G, Tana M, Mathieu G, Maggioni AP, Fontanella A, Campanini M, Mazzone A, Gussoni G, Dentali F.

Eur J Prev Cardiol. 2019 Apr;26(6):660-663. doi: 10.1177/2047487318795237. Epub 2018 Aug 28. No abstract available.

PMID:
30152250
11.

Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells.

Mortara L, Gariboldi MB, Bosi A, Bregni M, Pinotti G, Guasti L, Squizzato A, Noonan DM, Monti E, Campiotti L.

Target Oncol. 2018 Oct;13(5):657-665. doi: 10.1007/s11523-018-0586-x.

PMID:
30090970
12.
13.

Thyroid Disorders and Hemostasis.

Elbers LPB, Squizzato A, Gerdes VEA.

Semin Thromb Hemost. 2018 Oct;44(7):676-682. doi: 10.1055/s-0038-1666825. Epub 2018 Jul 25. Review.

PMID:
30045389
14.

Cytomegalovirus-associated splanchnic vein thrombosis in immunocompetent patients: A systematic review.

Bertoni M, Squizzato A, Foretic M, Zanieri S, Di Natale ME.

Thromb Res. 2018 Aug;168:104-113. doi: 10.1016/j.thromres.2018.06.015. Epub 2018 Jun 21. Review.

PMID:
29960252
15.

Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature.

Dentali F, Nigro O, Squizzato A, Gianni M, Zuretti F, Grandi AM, Guasti L.

Int J Cardiol. 2018 Sep 1;266:31-37. doi: 10.1016/j.ijcard.2018.02.116.

PMID:
29887466
16.

[EBM, guidelines, protocols: knowledge, attitudes and utilization in the era of law on professional responsibility and safety of health care.]

Minozzi S, Ruggiero F, Capobussi M, González-Lorenzo M, La Regina M, Squizzato A, Moja L, Orlandini F.

Recenti Prog Med. 2018 May;109(5):294-306. doi: 10.1701/2902.29247. Italian.

PMID:
29771251
17.

Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards.

Proietti M, Antoniazzi S, Monzani V, Santalucia P, Franchi C; SIM-AF Investigators, Fenoglio LM, Melchio R, Fabris F, Sartori MT, Manfredini R, De Giorgi A, Fabbian F, Biolo G, Zanetti M, Altamura N, Sabbà C, Suppressa P, Bandiera F, Usai C, Murialdo G, Fezza F, Marra A, Castelli F, Cattaneo F, Beccati V, di Minno G, Tufano A, Contaldi P, Lupattelli G, Bianconi V, Cappellini D, Hu C, Minonzio F, Fargion S, Burdick L, Francione P, Peyvandi F, Rossio R, Colombo G, Monzani V, Ceriani G, Lucchi T, Brignolo B, Manfellotto D, Caridi I, Corazza GR, Miceli E, Padula D, Fraternale G, Guasti L, Squizzato A, Maresca A, Liberato NL, Tognin T, Rozzini R, Bellucci FB, Muscaritoli M, Molfino A, Petrillo E, Dore M, Mete F, Gino M, Franceschi F, Gabrielli M, Perticone F, Perticone M, Bertolotti M, Mussi C, Borghi C, Strocchi E, Durazzo M, Fornengo P, Dallegri F, Ottonello LC, Salam K, Caserza L, Barbagallo M, Di Bella G, Annoni G, Bruni AA, Odetti P, Nencioni A, Monacelli F, Napolitano A, Brucato A, Valenti A, Castellino P, Zanoli L, Mazzeo M.

Eur J Intern Med. 2018 Jun;52:e12-e14. doi: 10.1016/j.ejim.2018.04.006. Epub 2018 Apr 12. No abstract available.

PMID:
29657108
18.

Direct-acting antiviral drugs for chronic hepatitis C and risk of major vascular events: a systematic review.

Tamborini Permunian E, Gervaso L, Gerdes V, Moja L, Guasti L, Squizzato A.

Intern Emerg Med. 2018 Aug;13(5):775-790. doi: 10.1007/s11739-018-1828-8. Epub 2018 Apr 2. Review.

PMID:
29611106
19.

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-comment.

Campiotti L, Sutter MB, Bolzacchini E, Squizzato A.

Intern Emerg Med. 2018 Jun;13(4):633-634. doi: 10.1007/s11739-018-1838-6. Epub 2018 Mar 27. No abstract available.

PMID:
29589265
20.

Cancer-associated ischemic stroke: A retrospective multicentre cohort study.

Grazioli S, Paciaroni M, Agnelli G, Acciarresi M, Alberti A, D'Amore C, Caso V, Venti M, Guasti L, Ageno W, Squizzato A.

Thromb Res. 2018 May;165:33-37. doi: 10.1016/j.thromres.2018.03.011. Epub 2018 Mar 15.

PMID:
29558659
21.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.

Squizzato A, Bellesini M, Takeda A, Middeldorp S, Donadini MP.

Cochrane Database Syst Rev. 2017 Dec 14;12:CD005158. doi: 10.1002/14651858.CD005158.pub4. Review.

22.

Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism.

Riva N, Puljak L, Moja L, Ageno W, Schünemann H, Magrini N, Squizzato A.

J Clin Epidemiol. 2018 May;97:1-13. doi: 10.1016/j.jclinepi.2017.11.012. Epub 2017 Nov 22.

PMID:
29175415
23.

Ruxolitinib-associated infections: A systematic review and meta-analysis.

Lussana F, Cattaneo M, Rambaldi A, Squizzato A.

Am J Hematol. 2018 Mar;93(3):339-347. doi: 10.1002/ajh.24976. Epub 2017 Dec 4.

24.

Stroke: Patients with CVT urgently need high-quality evidence.

Riva N, Squizzato A.

Nat Rev Neurol. 2017 Nov;13(11):644-646. doi: 10.1038/nrneurol.2017.143. Epub 2017 Oct 13. No abstract available.

PMID:
29027542
25.

In vitro effects of Apixaban on 5 different cancer cell lines.

Guasti L, Squizzato A, Moretto P, Vigetti D, Ageno W, Dentali F, Maresca AM, Campiotti L, Grandi AM, Passi A.

PLoS One. 2017 Oct 12;12(10):e0185035. doi: 10.1371/journal.pone.0185035. eCollection 2017.

26.

Derivation and validation of a novel bleeding risk score for elderly patients with venous thromboembolism on extended anticoagulation.

Seiler E, Limacher A, Mean M, Beer HJ, Osterwalder J, Frauchiger B, Righini M, Aschwanden M, Matter CM, Banyai M, Kucher N, Staub D, Lämmle B, Rodondi N, Squizzato A, Aujesky D.

Thromb Haemost. 2017 Aug 24;117(10). doi: 10.1160/TH-17-03-0162. [Epub ahead of print]

PMID:
28837210
27.

PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis.

Squizzato A, Suter MB, Nerone M, Giugliano RP, Dentali F, Maresca AM, Campiotti L, Grandi AM, Guasti L.

Intern Emerg Med. 2017 Oct;12(7):1043-1053. doi: 10.1007/s11739-017-1708-7. Epub 2017 Jul 10. Review.

PMID:
28695455
28.

Pulmonary embolism prognostic factors and length of hospital stay: A cohort study.

Donadini MP, Dentali F, Castellaneta M, Gnerre P, La Regina M, Masotti L, Pieralli F, Pomero F, Re R, Guasti L, Ageno W, Squizzato A; LORPELHS study group.

Thromb Res. 2017 Aug;156:155-159. doi: 10.1016/j.thromres.2017.06.009. Epub 2017 Jun 8.

PMID:
28646727
29.

Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis.

Squizzato A, Pomero F, Allione A, Priotto R, Riva N, Huisman MV, Klok FA, Stein PD, Guasti L, Fenoglio L, Dentali F, Ageno W.

Thromb Res. 2017 Jun;154:64-72. doi: 10.1016/j.thromres.2017.03.027. Epub 2017 Apr 7. Review.

PMID:
28427005
30.

Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis.

Campiotti L, Suter MB, Guasti L, Piazza R, Gambacorti-Passerini C, Grandi AM, Squizzato A.

Eur J Cancer. 2017 May;77:48-56. doi: 10.1016/j.ejca.2017.02.028. Epub 2017 Mar 30. Review.

PMID:
28365527
31.

Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH.

Squizzato A, Rancan E, Thachil J, Di Nisio M.

Thromb Res. 2017 Apr;152:74-76. doi: 10.1016/j.thromres.2017.02.021. Epub 2017 Feb 24. No abstract available.

PMID:
28262566
32.

Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome.

Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, Re R, Bonzini M.

Thromb Haemost. 2017 Apr 3;117(4):794-800. doi: 10.1160/TH16-10-0781. Epub 2017 Feb 9.

33.

Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials.

Elbers LP, Sjouke B, Zannad F, Cicoira M, Vizzardi E, Václavík J, Gerdes VE, Squizzato A.

Thromb Res. 2016 Aug;144:32-9. doi: 10.1016/j.thromres.2016.04.027. Epub 2016 May 7. Review. No abstract available.

PMID:
27270220
34.

Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review.

Squizzato A, Lussana F, Ageno W, Cattaneo M.

Intern Emerg Med. 2016 Apr;11(3):467-76. doi: 10.1007/s11739-016-1427-5. Epub 2016 Mar 15. Review.

PMID:
26980086
35.

Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment.

Guasti L, Maresca AM, Schembri L, Rasini E, Dentali F, Squizzato A, Klersy C, Robustelli Test L, Mongiardi C, Campiotti L, Ageno W, Grandi AM, Cosentino M, Marino F.

BMC Cardiovasc Disord. 2016 Jan 29;16:26. doi: 10.1186/s12872-016-0201-y.

36.

Supportive management strategies for disseminated intravascular coagulation. An international consensus.

Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Ten Cate H, Thachil J, Levi M, Vicente V, D'Angelo A, Di Nisio M.

Thromb Haemost. 2016 May 2;115(5):896-904. doi: 10.1160/TH15-09-0740. Epub 2015 Dec 17. Review.

PMID:
26676927
37.

Treating patients with cancer and acute venous thromboembolism.

Donadini MP, Squizzato A, Ageno W.

Expert Opin Pharmacother. 2016;17(4):535-43. doi: 10.1517/14656566.2016.1124857. Epub 2016 Jan 6. Review.

PMID:
26606049
38.

Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy.

Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M.

Thromb Haemost. 2016 Jan;115(2):399-405. doi: 10.1160/TH15-02-0172. Epub 2015 Sep 17.

PMID:
26422774
39.

Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.

Dentali F, Sironi AP, Gianni M, Orlandini F, Guasti L, Grandi AM, Franchini M, Ageno W, Squizzato A.

Semin Thromb Hemost. 2015 Oct;41(7):774-87. doi: 10.1055/s-0035-1564042. Epub 2015 Sep 26. Review.

PMID:
26408921
40.

Thrombosis Associated with Viral Hepatitis.

Galli L, Gerdes VE, Guasti L, Squizzato A.

J Clin Transl Hepatol. 2014 Dec;2(4):234-9. doi: 10.14218/JCTH.2014.00031. Epub 2014 Dec 15. Review.

41.

Point-of-care ultrasound in the diagnosis of pulmonary embolism.

Squizzato A, Galli L, Gerdes VE.

Crit Ultrasound J. 2015 May 27;7:7. doi: 10.1186/s13089-015-0025-5. eCollection 2015. Review.

42.

Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis.

Di Nisio M, Thachil J, Squizzato A.

Thromb Res. 2015 Aug;136(2):239-42. doi: 10.1016/j.thromres.2015.05.022. Epub 2015 May 23.

PMID:
26033399
43.

Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature.

Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W.

Intern Emerg Med. 2015 Jun;10(4):507-14. doi: 10.1007/s11739-015-1249-x. Epub 2015 May 16. Review.

PMID:
25982918
44.

Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.

Squizzato A, Lussana F, Cattaneo M.

Thromb Haemost. 2015 Aug;114(2):237-44. doi: 10.1160/TH15-01-0073. Epub 2015 May 7. Review.

PMID:
25946985
45.

Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data.

Tamborini Permunian E, Riva N, Guasti L, Squizzato A.

Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):625-37. doi: 10.1517/17425255.2015.1021330. Epub 2015 Mar 1. Review.

PMID:
25728292
46.

The role of thrombolytic therapy in pulmonary embolism.

Wang TF, Squizzato A, Dentali F, Ageno W.

Blood. 2015 Apr 2;125(14):2191-9. doi: 10.1182/blood-2014-08-559278. Epub 2015 Jan 28. Review. No abstract available.

47.

Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis.

Stuijver DJ, Romualdi E, van Zaane B, Bax L, Büller HR, Gerdes VE, Squizzato A.

Intern Emerg Med. 2015 Mar;10(2):219-46. doi: 10.1007/s11739-014-1168-2. Epub 2014 Dec 13.

PMID:
25502591
48.

How I treat splanchnic vein thrombosis.

Ageno W, Dentali F, Squizzato A.

Blood. 2014 Dec 11;124(25):3685-91. doi: 10.1182/blood-2014-07-551515. Epub 2014 Oct 15.

49.

Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study.

Ferrari M, Romualdi E, Dentali F, Squizzato A, Marino F, Cosentino M, Ageno W.

Thromb Res. 2014 Dec;134(6):1359-62. doi: 10.1016/j.thromres.2014.09.017. Epub 2014 Sep 20. No abstract available.

PMID:
25300812
50.

Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis.

Ageno W, Di Minno MN, Ay C, Jang MJ, Hansen JB, Steffen LM, Vayà A, Rattazzi M, Pabinger I, Oh D, Di Minno G, Braekkan SK, Cushman M, Bonet E, Pauletto P, Squizzato A, Dentali F.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2478-85. doi: 10.1161/ATVBAHA.114.304085. Epub 2014 Sep 11.

Supplemental Content

Loading ...
Support Center